Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism

International Journal of Surgery

Volumn 28, Issue , 2016, Pages 179-184

  Ziegler, Kathryn M ^a   Considine, Robert V ^a   True, Eben ^a   Swartz Basile, Deborah A ^a   Pitt, Henry A ^b   Zyromski, Nicholas J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocytes; Hepatocyte growth factor; Obesity; Pancreatic cancer

Indexed keywords

CRIZOTINIB; RECOMBINANT PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; MOUSE; MTT ASSAY; NONHUMAN; OBESITY; PAN02 CELL LINE; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; TGP 47 CELL LINE; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; HUMAN; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADIPOCYTES; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 84960929008     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2016.03.002     Document Type: Article

References (28)

1. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348(17):1625-1638.
2. Stolzenberg-Solomon R.Z., Adams K., Leitzmann M., Schairer C., Michaud D.S., Hollenbeck A., et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am. J. Epidemiol. 2008, 167(5):586-597.
3. Berrington de Gonzalez A., Sweetland S., Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br. J. Cancer 2003, 89(3):519-523.
4. Li D., Morris J.S., Liu J., Hassan M.M., Day R.S., Bondy M.L., et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. Jama 2009, 301(24):2553-2562.
5. House M.G., Fong Y., Arnaoutakis D.J., Sharma R., Winston C.B., Protic M., et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J. Gastrointest. Surg. 2008, 12(2):270-278.
6. Fleming J.B., Gonzalez R.J., Petzel M.Q., Lin E., Morris J.S., Gomez H., et al. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Archives Surg. 2009, 144(3):216-221.
7. Benns M., Woodall C., Scoggins C., McMasters K., Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann. Surg. Oncol. 2009, 16(9):2565-2569.
8. Williams T.K., Rosato E.L., Kennedy E.P., Chojnacki K.A., Andrel J., Hyslop T., et al. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J. Am. Coll. Surg. 2009, 208(2):210-217.
9. Mathur A., Zyromski N.J., Pitt H.A., Al-Azzawi H., Walker J.J., Saxena R., et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J. Am. Coll. Surg. 2009, 208(5):989-994.
10. Zyromski N.J., Mathur A., Pitt H.A., Wade T.E., Wang S., Nakshatri P., et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 2009, 146(2):258-263.
11. Halberg N., Wernstedt-Asterholm I., Scherer P.E. The adipocyte as an endocrine cell. Endocrinol. Metabol. Clin. N. Am. 2008, 37(3):753-768.
12. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109(10):1292-1298.
13. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145(5):2273-2282.
14. Fain J.N., Buehrer B., Bahouth S.W., Tichansky D.S., Madan A.K. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabol. Clin. Exp. 2008, 57(7):1005-1015.
15. Bell L.N., Cai L., Johnstone B.H., Traktuev D.O., March K.L., Considine R.V. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am. J. Physiol. Endocrinol. Metabol. 2008, 294(2). E336-E44.
16. Zhang Y., Daquinag A., Traktuev D.O., Amaya-Manzanares F., Simmons P.J., March K.L., et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 2009, 69(12):5259-5266.
17. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998, 97(4):381-390.
18. Bell L.N., Ward J.L., Degawa-Yamauchi M., Bovenkerk J.E., Jones R., Cacucci B.M., et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am. J. Physiol. Endocrinol. Metabol. 2006, 291(4). E843-E8.
19. Ide T., Kitajima Y., Miyoshi A., Ohtsuka T., Mitsuno M., Ohtaka K., et al. The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Ann. Surg. Oncol. 2007, 14(9):2600-2607.
20. Qian L.W., Mizumoto K., Maehara N., Ohuchida K., Inadome N., Saimura M., et al. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett. 2003, 190(1):105-112.
21. Matsushita A., Gotze T., Korc M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 2007, 67(21):10309-10316.
22. Bauer T.W., Somcio R.J., Fan F., Liu W., Johnson M., Lesslie D.P., et al. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol. Cancer Ther. 2006, 5(7):1676-1682.
23. Kitajima Y., Ide T., Ohtsuka T., Miyazaki K. Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci. 2008, 99(7):1341-1347.
24. Mathur A., Pitt H.A., Marine M., Saxena R., Schmidt C.M., Howard T.J., et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann. Surg. 2007, 246(6):1058-1064.
25. Manabe Y., Toda S., Miyazaki K., Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J. Pathol. 2003, 201(2):221-228.
26. Somasundar P., Frankenberry K.A., Skinner H., Vedula G., McFadden D.W., Riggs D., et al. Prostate cancer cell proliferation is influenced by leptin. J. Surg. Res. 2004, 118(1):71-82.
27. Berger N.A. Obesity and cancer pathogenesis. Ann. N. Y. Acad. Sci. 2014, 1311:57-76.
28. Preziosi G., Oben J.A., Fusai G. Obesity and pancreatic cancer. Surg. Oncol. 2014, 23(2):61-71.